Medical device and MedTech insights, news, tips and more

Stryker Makes Takeover Approach to Boston Scientific

June 11, 2018


Boston Scientific shares rose nearly 7 percent Monday after the Wall Street Journal reported rival medical device manufacturer Stryker approached it with a takeover bid.

A deal would combine two medical device giants into a powerhouse with a combined value of more than $110 billion, The Wall Street Journal reported, citing people familiar with the matter. Sources told the news outlet it was unclear whether Boston is receptive to the offer.

Boston has a market capitalization of $47.6 billion. Its shares have risen 38 percent this year. Stryker, with a market capitalization of $64.9 billion, has seen its shares gain about 13 percent his year. They dipped more than 2 percent on Monday.

Read More at the Source: Boston Scientific shares rise on report Stryker made takeover offer

By: Michael Sheetz & Angelica LaVito


A Speciality Recruiting Firm Exclusively Servicing The Medical Device Industry

Legacy MedSearch has more than 30 years of combined experience recruiting in the medical device industry. We pride ourselves on our professionalism and ability to communicate quickly and honestly with all parties in the hiring process. Our clients include both blue-chip companies and innovative startups within the MedTech space. Over the past 10 years, we have built one of the strongest networks of device professionals ranging from sales, marketing, research & development, quality & regulatory, project management, field service, and clinical affairs.

We offer a variety of different solutions for hiring managers depending on the scope and scale of each individual search. We craft a personalized solution for each client and position with a focus on attracting the best possible talent in the shortest possible time frame.

Are you hiring?
Contact us to discuss partnering with Legacy MedSearch on your position.

More insights

March 7, 2024
FDA Clears Dexcom’s First Over-the-Counter Continuous Glucose Monitor
Learn More
March 1, 2024
FDA greenlights Boston Scientific’s Novel Drug-Coated Balloon for Coronary In-Stent Restenosis
Learn More
February 21, 2024
Sparrow BioAcoustics Launches Software That Turns a Smartphone into a Stethoscope 
Learn More

Begin your legacy now. We are your medtech and medical device talent advisory firm.